MARKET

DYAI

DYAI

Dyadic Intl Inc Del
NASDAQ
0.7299
+0.0512
+7.54%
After Hours: 0.7535 +0.0236 +3.23% 18:41 03/30 EDT
OPEN
0.6930
PREV CLOSE
0.6787
HIGH
0.7959
LOW
0.6600
VOLUME
81.93K
TURNOVER
--
52 WEEK HIGH
1.430
52 WEEK LOW
0.6546
MARKET CAP
26.60M
P/E (TTM)
-3.0784
1D
5D
1M
3M
1Y
5Y
1D
Dyadic International Gets Nasdaq Warning Over Listing Rules, Faces Delisting Risk
Benzinga · 23h ago
Dyadic receives Nasdaq notice for failing continued listing financial requirements
Reuters · 23h ago
Weekly Report: what happened at DYAI last week (0323-0327)?
Weekly Report · 1d ago
Dyadic International Earnings Call Highlights Commercial Pivot
TipRanks · 2d ago
Analysts Are Bullish on These Healthcare Stocks: Dianthus Therapeutics (DNTH), Cardiff Oncology (CRDF)
TipRanks · 4d ago
Dyadic International GAAP EPS of -$0.23 in-line, revenue of $3.09M misses by $0.77M
Seeking Alpha · 5d ago
Dyadic outlines 2026 product revenue growth and commercialization milestones while expanding partnerships
Seeking Alpha · 5d ago
Dyadic International 2025 revenue falls, net loss widens 
Reuters · 5d ago
More
About DYAI
Dyadic International, Inc. is a biotechnology company focused on the large-scale manufacture of proteins for use in human and animal vaccines and therapeutics and for use in non-pharmaceutical applications including food, nutrition, and wellness. The Company's gene expression and protein production platforms are based on the highly productive and scalable fungus Thermothelomyces heterothallica, which the Company named C1. The Compny’s lead technology, C1-cell protein production platform, is based on an industrially proven microorganism (named C1), which is used to speed development and improve performance of biologic vaccines and drugs at flexible commercial scales for the human and animal health markets. The Company has also developed the Dapibus filamentous fungal based microbial protein production platform to enable the rapid development and large-scale manufacture of low-cost proteins, metabolites, and other biologic products for use in non-pharmaceutical applications.

Webull offers Dyadic International Inc stock information, including NASDAQ: DYAI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DYAI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DYAI stock methods without spending real money on the virtual paper trading platform.